Shares of ResMed Inc. RMD inched 0.51% higher to $246.18 Monday, on what proved to be an all-around great trading session for ...

Healthcare technology company ResMed's (NYSE: RMD) stock wasn't quite the picture of health on Wednesday. The shares lost ...

Wolfe Research downgraded shares of the maker of sleep-apnea airway machines to Underperform from Peer Perform.

To get a sense of who is truly in control of ResMed Inc. ( NYSE:RMD ), it is important to understand the ownership structure ...

ResMed's AirSense 11 platform and myAir app enhance patient engagement and efficiency. Check out why I remain bullish on RMD ...

根据最近的SEC文件显示，ResMed Inc.（纽交所代码：RMD）的首席商务官（SaaS）Kaushik Ghoshal于9月12日出售了公司5,000股股票，净收入超过120万美元。这些股票以平均252.56美元的价格售出，交易总额为1,262,800美元。

ResMed achieved double-digit revenue growth through acquisitions and operating efficiencies, with improving capital ...

ResMed Inc. (NYSE:RMD) 报告称，其首席财务官Brett Sandercock于2024年9月9日出售了公司股票。根据文件显示，Sandercock以每股246.42美元的价格出售了1,000股ResMed普通股，总计246,420美元。

Polark's pessimism stems from concerns that Resmed might be poised to lose market share to its pharmaceutical rival Eli Lilly ...

ResMed faces a 3% drop in share price after concerns over Eli Lilly’s Ozempic, which could impact the demand for CPAP ...

ResMed Inc. closed $4.30 below its 52-week high ($255.18), which the company reached on September 9th.

*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...